VEGFA and cancer: It should be mentioned that although passive immunotherapy treatments with antibodies that bind VEGF or its receptors are widely applied in modern cancer therapy, their long-term safety remains under debate due to the adverse effects experienced by cancer patients in their healthy vasculature across various tissue types and organs [130].